COVID-19 |


Division of Neuroscience, Development and Aging DNDA
Emerging Technologies and Training in Neurosciences ETTN
Study Section:
Small Business: Drug Discovery for Aging, Neuropsychiatric and Neurologic Disorders ETTN (14)

Dr. Rudolph earned his Ph.D. in pharmacology from the University of Florida, where he studied the effects of chronic ethanol exposure on NMDA receptor pharmacology and physiology. He first came to the NIH intramural program as an IRTA Fellow, studying the genetics of alcoholism and other mental disorders in the NIAAA Laboratory of Neurogenetics. Before coming to CSR, Dr. Rudolph was the group leader of the Applied Genomics and Molecular Genetics Core Facility, at Transgenomic, Inc., in Gaithersburg, MD.